Phase I of this
feasibility study is approved for use through 10/92 under the
following conditions: 1) Prior to fielding the instrument, NIDA:(a)
justifies the practical utility of interviewer problem severity
rating questions (e.g. questio D8) and explains how inter rater
reliability will be ensured for such questions; and (b) justifies
the validity of responses to questions su as J6a. and J18a. which
ask clients whether physical or emotional problems were due to drug
use. In the absence of adequate justification from the Department,
OMB may ask that such questions be deleted from the instrument
prior to use. 2) No later than 12/91, NIDA provides OMB with a
comprehensive explanation of its plans to evaluate potential bias
in non participati programs, client non respondents, and item
specific non response. In addition, NIDA should present a plan for:
1) validation of client responses in all outcome categories; and 2)
controlling for facility bias in administering the survey and
responding to the Program Directo questionnaire. Finally, NIDA
should articulate how results from NDATU or the Drug Research Study
could be used to supplant or validate treatment program responses.
3) NIDA concentrates on the development of a case mix measurement
and adjustment methodology in Phase I of this effort and will
present this methodology in its next package for OMB clearance.
(continued)
Inventory as of this Action
Requested
Previously Approved
10/31/1992
10/31/1992
5,430
0
0
3,511
0
0
0
0
0
THE PROJECT EXAMINES THE FEASIBILITY
OF A PERFORMANCE REPORTING SYSTEM FOR METHADONE TREATMENT PROGRAMS.
RELATIVE PERFORMANCE ON OBJECTIVE, VERIFIABLE OUTCOMES WILL BE
ASSESSED CONSIDERING CLIENT CASE-MIX. INFORMATION FROM PERFORMANCE
REPORTS TO PROGRAMS WILL ASSIST IN IMPROVING THE QUALITY OF
TREATMENT THEY PROVIDE. THIS SUBMISSION IS F THE FIELD TEST ONLY TO
DEVELOP INSTRUMENT AND PROCEDURES.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.